NO952796D0 - Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater - Google Patents

Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater

Info

Publication number
NO952796D0
NO952796D0 NO952796A NO952796A NO952796D0 NO 952796 D0 NO952796 D0 NO 952796D0 NO 952796 A NO952796 A NO 952796A NO 952796 A NO952796 A NO 952796A NO 952796 D0 NO952796 D0 NO 952796D0
Authority
NO
Norway
Prior art keywords
sub
oxidizable
crepes
site
preparation
Prior art date
Application number
NO952796A
Other languages
English (en)
Norwegian (no)
Inventor
Rolf Berge
Jon Songstad
Original Assignee
Rolf Berge
Jon Songstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolf Berge, Jon Songstad filed Critical Rolf Berge
Priority to NO952796A priority Critical patent/NO952796D0/no
Publication of NO952796D0 publication Critical patent/NO952796D0/no
Priority to PCT/NO1995/000195 priority patent/WO1997003663A1/en
Priority to CA002226871A priority patent/CA2226871A1/en
Priority to ES95941241T priority patent/ES2183889T3/es
Priority to DE69528291T priority patent/DE69528291T2/de
Priority to EP02075955A priority patent/EP1232750A1/de
Priority to DK95941241T priority patent/DK0840604T3/da
Priority to PT95941241T priority patent/PT840604E/pt
Priority to AU42726/96A priority patent/AU4272696A/en
Priority to US08/981,956 priority patent/US6046237A/en
Priority to AT95941241T priority patent/ATE224188T1/de
Priority to EP95941241A priority patent/EP0840604B1/de
Priority to JP50656797A priority patent/JP3553966B2/ja
Priority to KR19980700295A priority patent/KR100394986B1/ko
Priority to EP02075954A priority patent/EP1232749A1/de
Priority to AU61243/00A priority patent/AU734431B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO952796A 1995-07-14 1995-07-14 Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater NO952796D0 (no)

Priority Applications (16)

Application Number Priority Date Filing Date Title
NO952796A NO952796D0 (no) 1995-07-14 1995-07-14 Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
EP02075954A EP1232749A1 (de) 1995-07-14 1995-10-25 Nicht-beta-oxidierbaren Fettsäureanalogen und ihre Verwendung zur Hemmung der oxidativen Veränderungen von Lipoproteinen geringer Dichte (LDL)
DK95941241T DK0840604T3 (da) 1995-07-14 1995-10-25 Ikke-beta-oxiderbare fedtsyreanaloger, anvendelse heraf som terapeutisk aktive medikamenter og fremstilling deraf
AU42726/96A AU4272696A (en) 1995-07-14 1995-10-25 Non-beta-oxidizable fatty acid analogues, their uses as therpeutic active medicaments, and preparation thereof
ES95941241T ES2183889T3 (es) 1995-07-14 1995-10-25 Analogos de acidos grasos no beta-oxidables, sus usos como medicamentos terapeuticamente activos y su preparacion.
DE69528291T DE69528291T2 (de) 1995-07-14 1995-10-25 Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung
EP02075955A EP1232750A1 (de) 1995-07-14 1995-10-25 Nicht-beta-oxidierbaren Fettsäureanalogen und ihre Verwendung zur Hemmung des Wachstums von Krebszellen
PCT/NO1995/000195 WO1997003663A1 (en) 1995-07-14 1995-10-25 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF
PT95941241T PT840604E (pt) 1995-07-14 1995-10-25 Analogos de acidos gordos nao beta-oxidaveis sua utilizacao como medicamentos terapeuticos activos e sua preparacao
CA002226871A CA2226871A1 (en) 1995-07-14 1995-10-25 Non-.beta.-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof
US08/981,956 US6046237A (en) 1995-07-14 1995-10-25 Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments
AT95941241T ATE224188T1 (de) 1995-07-14 1995-10-25 Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung
EP95941241A EP0840604B1 (de) 1995-07-14 1995-10-25 Nicht-beta oxidierbare fettsäureanaloge,deren verwendung als therapeutisch wirksame medikamente sowie deren herstellung
JP50656797A JP3553966B2 (ja) 1995-07-14 1995-10-25 非−β−酸化可能脂肪酸類似体、治療用活性薬剤としてのその利用及びその調製方法
KR19980700295A KR100394986B1 (ko) 1995-07-14 1995-10-25 비-베타-산화성지방산유사체를주성분으로하는치료용약제
AU61243/00A AU734431B2 (en) 1995-07-14 2000-09-21 Non-beta-oxidizable fatty analogues, their uses as therapeutic active medicaments, and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO952796A NO952796D0 (no) 1995-07-14 1995-07-14 Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater

Publications (1)

Publication Number Publication Date
NO952796D0 true NO952796D0 (no) 1995-07-14

Family

ID=19898394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952796A NO952796D0 (no) 1995-07-14 1995-07-14 Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater

Country Status (13)

Country Link
US (1) US6046237A (de)
EP (3) EP1232750A1 (de)
JP (1) JP3553966B2 (de)
KR (1) KR100394986B1 (de)
AT (1) ATE224188T1 (de)
AU (2) AU4272696A (de)
CA (1) CA2226871A1 (de)
DE (1) DE69528291T2 (de)
DK (1) DK0840604T3 (de)
ES (1) ES2183889T3 (de)
NO (1) NO952796D0 (de)
PT (1) PT840604E (de)
WO (1) WO1997003663A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
AU784116B2 (en) * 1999-09-17 2006-02-09 Peplin Biolipids Pty Ltd Anti-cancer nitro- and thia-fatty acids
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
NO20003591L (no) * 2000-07-13 2002-01-14 Thia Medica As Fettsyreanaloger for behandling av kreft
NO20006008L (no) * 2000-11-28 2002-05-29 Thia Medica As Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7314953B2 (en) * 2001-03-27 2008-01-01 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
EP1511477A4 (de) * 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc Histondeacetylase-hemmer auf basis von alpha-ketoepoxid-verbindungen
NZ537762A (en) 2002-06-20 2007-02-23 Thia Medica As Sulfur-containing phospholipid derivatives
FR2850650B1 (fr) * 2003-01-31 2005-03-25 Genfit S A Utilisation therapeutique d'acylglycerols et de leurs analogues azotes et sulfures
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
US20090215895A1 (en) * 2004-01-30 2009-08-27 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
RU2388490C2 (ru) * 2004-07-19 2010-05-10 Тиа Медика Ас Композиция, содержащая растительный или рыбий жир, и соединения, содержащие неокисляющиеся структурные элементы жирных кислот
JP2008506774A (ja) * 2004-07-19 2008-03-06 ティア メディカ アクスイェ セルスカプ タンパク質材料と非酸化性脂肪酸体を含む組成物
US20060160902A1 (en) * 2004-11-08 2006-07-20 Wiech Norbert L Histone deacetylase inhibitors
CA2904898C (en) 2013-03-11 2019-10-15 Jan Remmereit Lipid compositions containing bioactive fatty acids
AU2014229506B2 (en) 2013-03-11 2017-04-13 Nobesita As Natural lipids containing non-oxidizable fatty acids
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2208533A1 (de) * 1972-02-23 1973-09-27 Kolmar Laboratories Neue alkylthioaether
GB8813012D0 (en) * 1988-06-02 1988-07-06 Norsk Hydro As Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals

Also Published As

Publication number Publication date
JPH11514339A (ja) 1999-12-07
DE69528291D1 (de) 2002-10-24
JP3553966B2 (ja) 2004-08-11
AU4272696A (en) 1997-02-18
DK0840604T3 (da) 2002-12-30
DE69528291T2 (de) 2003-05-08
EP0840604B1 (de) 2002-09-18
PT840604E (pt) 2003-01-31
ATE224188T1 (de) 2002-10-15
US6046237A (en) 2000-04-04
KR19990028993A (ko) 1999-04-15
ES2183889T3 (es) 2003-04-01
EP1232750A1 (de) 2002-08-21
KR100394986B1 (ko) 2004-01-24
WO1997003663A1 (en) 1997-02-06
EP0840604A1 (de) 1998-05-13
CA2226871A1 (en) 1997-02-06
AU6124300A (en) 2000-11-30
AU734431B2 (en) 2001-06-14
EP1232749A1 (de) 2002-08-21

Similar Documents

Publication Publication Date Title
NO952796D0 (no) Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
GB8813012D0 (en) Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals
AU8682191A (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
JO1850B1 (en) New erythromycin derivatives, methods of preparation and uses as a drug
HUP0004071A2 (hu) Prosztaglandin-származékokat tartalmazó gyógyszerkészítmények
MX9606665A (es) Derivados de acido 3-amino-2-mercaptobenzoico y procesos para su preparacion.
DE50105496D1 (de) Verwendung schaumarmer, tensidhaltiger percarbonsaüre-mittel zur cip-desinfektion
IE781072L (en) Pyridobenzodiazepines¹¹¹¹¹¹¹¹¹¹¹¹¹¹¹pharmaceuticals
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
ES8404694A1 (es) Procedimiento de preparacion de nuevos derivos de amino-14 esteroides
IE44627L (en) m-TRIFLUOROMETHYLPHENYL-PIPERIDINES.
AU553893B2 (en) Imidazolidine derivatives
AU572612B2 (en) Isoxazole derivatives
NZ221137A (en) 14,17b-ethano-14b-estratrienes and pharmaceutical compositions
AP1518A (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
AU586477B2 (en) Hexenoic acids
SE9701912D0 (sv) Pharmaceutical composition and use thereof
AU6306886A (en) Alkylcarboxamides of pyridylalkylamines, their preparation and their use in human and veterinary medicine
ES8104188A1 (es) Un procedimiento para la preparacion de nuevas 3-fenilpropi-laminas n-sustituidas
ES8201525A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,1'-bifenil-2-il-alquilamina
ES480594A1 (es) Procedimiento para la preparacion de nuevas cetoaminas ci- cloalifaticas.
ATE127774T1 (de) Verfahren zur herstellung von bicyclo(3.2.0)hept- 2-en-7-onen.
EP0169725A3 (en) New method of treatment using prostaglandin analogues
ES2071832T3 (es) Procedimiento para la preparacion de derivados de 21-bromo-4-pregneno-3,20-diona.
IE44093L (en) Salts of p-chlorophenoxy acetic acid dimethylaminoethyl¹ester